Success Metrics

Clinical Success Rate
100.0%

Based on 5 completed trials

Completion Rate
100%(5/5)
Active Trials
0(0%)
Results Posted
80%(4 trials)

Phase Distribution

Ph phase_1
1
20%
Ph phase_2
2
40%
Ph phase_3
2
40%

Phase Distribution

1

Early Stage

2

Mid Stage

2

Late Stage

Phase Distribution5 total trials
Phase 1Safety & dosage
1(20.0%)
Phase 2Efficacy & side effects
2(40.0%)
Phase 3Large-scale testing
2(40.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

5 of 5 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

5

all time

Status Distribution
Completed(5)

Detailed Status

Completed5

Development Timeline

Analytics

Development Status

Total Trials
5
Active
0
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 11 (20.0%)
Phase 22 (40.0%)
Phase 32 (40.0%)

Trials by Status

completed5100%

Recent Activity

0 active trials
Showing 5 of 5
completedphase_2

OTL38 Injection for Intraoperative Imaging of Folate Receptor Positive Lung Nodules

NCT02872701
completedphase_3

ELUCIDATE: Enabling Lung Cancer Identification Using Folate Receptor Targeting

NCT04241315
completedphase_2

Phase 2 Study of OTL38 for Intra-operative Imaging of Folate Receptor-alpha Positive Ovarian Cancer

NCT02317705
completedphase_1

Intraoperative Imaging of Pulmonary Nodules by SGM-101

NCT04315467
completedphase_3

OTL38 for Intra-operative Imaging of Folate Receptor Positive Ovarian Cancer

NCT03180307

Clinical Trials (5)

Showing 5 of 5 trials
NCT02872701Phase 2

OTL38 Injection for Intraoperative Imaging of Folate Receptor Positive Lung Nodules

Completed
NCT04241315Phase 3

ELUCIDATE: Enabling Lung Cancer Identification Using Folate Receptor Targeting

Completed
NCT02317705Phase 2

Phase 2 Study of OTL38 for Intra-operative Imaging of Folate Receptor-alpha Positive Ovarian Cancer

Completed
NCT04315467Phase 1

Intraoperative Imaging of Pulmonary Nodules by SGM-101

Completed
NCT03180307Phase 3

OTL38 for Intra-operative Imaging of Folate Receptor Positive Ovarian Cancer

Completed

All 5 trials loaded

Drug Details

Intervention Type
DEVICE
Total Trials
5